NEW YORK (GenomeWeb News) – GenoSpace, PathGroup, and Thomson Reuters' IP & Science business today announced an initiative aimed at personalized medicine in oncology.

The partners will combine their resources, technologies, and expertise to integrate PathGroup's SmartGenomics next generation DNA sequencing and cytogenomic array with traditional pathology assays, enabling genetic profiling that may lead to greater insights into disease and patient treatment options, they said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.